Skip to main navigation Skip to search Skip to main content

Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients

  • Raija Silvennoinen
  • , Veli Kairisto
  • , Tarja-Terttu Pelliniemi
  • , Mervi Putkonen
  • , Pekka Anttila
  • , Marjaana Saily
  • , Anu Sikio
  • , Jorma Opas
  • , Karri Penttila
  • , Taru Kuittinen
  • , Tuomo Honkanen
  • , Tuija Lundan
  • , Vesa Juvonen
  • , Tiina Luukkaala
  • , Kari Remes

Research output: Contribution to journalArticleScientific

Original languageEnglish
JournalBritish Journal of Haematology
Volume160
Issue number4
Pages (from-to)561-564
Number of pages4
ISSN0007-1048
DOIs
Publication statusPublished - Feb 2013
MoE publication typeB1 Journal article

Fields of Science

  • multiple myeloma
  • minimal residual disease
  • molecular genetics
  • bortezomib
  • stem cell transplantation1
  • MINIMAL RESIDUAL DISEASE
  • QUANTITATIVE ASO-PCR
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this